• Autoinflammatory Primary Immunodeficiency (PID) Gene Panel
  • Cardiovascular risk assessment
  • Plasminogen Activity, Plasma
  • Hydrocodone, Urine
  • Idiopathic thrombocytopenic purpura
  • CYFRA 21-1 (Cytokeratin 19 Fragment), Serum
  • Secobarbital, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Aspartoacylase (ASPA) Gene Mutation Analysis (Canavan Disease)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Aspartoacylase (ASPA) Gene Mutation Analysis (Canavan Disease)
Medical Test

Reference Ranges
Access to Aspartoacylase (ASPA) Gene Mutation Analysis (Canavan Disease) is restricted.